id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-C-1951-0233,FDA,FDA-2017-C-1951,Request for Hearing from Covington & Burling LLP,Other,Request for Hearing,2018-12-12T05:00:00Z,2018,12,2018-12-12T05:00:00Z,,2018-12-12T19:02:06Z,,0,0,090000648391bf8d
FDA-2017-C-1951-0228,FDA,FDA-2017-C-1951,05) FDA-2017-C-1951-NTP Monograph on Health Effects of Low-Level Lead,Supporting & Related Material,Background Material,2018-10-31T04:00:00Z,2018,10,,,2018-10-31T13:34:10Z,,0,0,09000064838739af
FDA-2017-C-1951-0223,FDA,FDA-2017-C-1951,Termination of Listing of Color Additive Exempt From Certification; Lead Acetate,Rule,Final Rule,2018-10-31T04:00:00Z,2018,10,2018-10-31T04:00:00Z,2018-12-01T04:59:59Z,2018-12-13T02:06:35Z,2018-23725,0,0,090000648387332c
FDA-2017-C-1951-0224,FDA,FDA-2017-C-1951,1)-FDA-2017-C-1951-List of References,Supporting & Related Material,Background Material,2018-10-31T04:00:00Z,2018,10,,,2018-10-31T13:28:49Z,,0,0,09000064838739ab
FDA-2017-C-1951-0227,FDA,FDA-2017-C-1951,04) FDA-2017-C-1951-ATSDR Tox Profile for Lead,Supporting & Related Material,Background Material,2018-10-31T04:00:00Z,2018,10,,,2018-10-31T13:31:55Z,,0,0,09000064838739ae
FDA-2017-C-1951-0225,FDA,FDA-2017-C-1951,02) FDA-2017-C-1951-Lead Acetate Toxicology review Memorandum_Redacted,Supporting & Related Material,Background Material,2018-10-31T04:00:00Z,2018,10,,,2018-10-31T13:29:39Z,,0,0,09000064838739ac
FDA-2017-C-1951-0229,FDA,FDA-2017-C-1951,06) FDA-2017-C-1951-Fourth National Report on Human Exposure to Environmental Chemicals_Volume1_Mar2018,Supporting & Related Material,Background Material,2018-10-31T04:00:00Z,2018,10,,,2018-10-31T13:36:46Z,,0,0,09000064838739b0
FDA-2017-C-1951-0226,FDA,FDA-2017-C-1951,03) FDA-2017-C-1951-Lead Acetate Chemistry Memorandum_Redacted,Supporting & Related Material,Background Material,2018-10-31T04:00:00Z,2018,10,,,2018-10-31T13:30:45Z,,0,0,09000064838739ad